Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.73 |
| ▸ | MEN1 | O00255 | 3/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.73 |
| ▸ | HKDC1 | Q2TB90 | 2/20 | 0.73 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.73 |
| ▸ | USP2 | O75604 | 1/20 | 0.73 |
| ▸ | TP53 | P04637 | 1/20 | 0.73 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.73 |
| ▸ | ALOX5 | P09917 | 6/20 | 0.59 |
| ▸ | PTGS2 | P35354 | 6/20 | 0.59 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.48 |
| ▸ | CDC25A | P30304 | 2/20 | 0.47 |
| ▸ | CDC25B | P30305 | 2/20 | 0.47 |
| ▸ | CDC25C | P30307 | 1/20 | 0.47 |
| ▸ | TEK | Q02763 | 2/20 | 0.46 |
| ▸ | GLS2 | Q9UI32 | 1/20 | 0.46 |
| ▸ | TYR | P14679 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2,6-Dimethoxyquinone SCHEMBL570683 | 0.85 | HKDC1 (1.00) | MAPTMEN1KMT2AHKDC1MAPK1 | |
| SCHEMBL13452596 | 0.81 | MEN1 (0.52) | MAPTMEN1KMT2AHKDC1MAPK1 | |
| Ubiquinone Qo SCHEMBL6760403 | 0.78 | HKDC1 (0.63) | MAPTMEN1KMT2AHKDC1MAPK1 | |
| SCHEMBL21463 | 0.76 | MAPT (0.41) | MAPTMEN1KMT2AHKDC1MAPK1 | |
| SCHEMBL11238984 | 0.76 | CDC25B (0.42) | MAPTMEN1KMT2AHKDC1MAPK1 | |
| SCHEMBL13780438 | 0.76 | TYR (0.64) | MAPTMEN1KMT2AHKDC1MAPK1 | |
| SCHEMBL7115894 | 0.74 | ALOX5 (1.00) | MAPTMEN1KMT2AHKDC1MAPK1 | |
| SCHEMBL21729822 | 0.74 | HKDC1 (0.70) | MAPTMEN1KMT2AHKDC1MAPK1 | |
| SCHEMBL9364524 | 0.74 | MAPT (0.70) | MAPTMEN1KMT2AHKDC1MAPK1 | |
| SCHEMBL13780447 | 0.74 | TYR (0.68) | MAPTMEN1KMT2AHKDC1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220409554-A1 | ASCORBIC ACID AND QUINONE COMPOUND FOR CANCER TREATMENT | IC-MedTech Corp. | 2022-12-29 | — | — | US | claimed |
| CN-109554712-B | Composition of gas phase corrosion inhibitor and its use and preparation method | 艾克索防腐研究有限公司 | 2021-02-09 | — | — | CN | claimed |
| US-10753000-B2 | Compositions of vapor phase corrosion inhibitors and their use as well as methods for their manufacture | EXCOR KORROSIONSFORSCHUNG GMBH (DE) | 2020-08-25 | — | — | US | claimed |
| EP-3461931-B1 | COMPOSITIONS OF VAPOUR PHASE CORROSION INHIBITORS AND THEIR USE AND METHOD FOR PREPARING THEM | EXCOR KORROSIONSFORSCHUNG GMBH (DE) | 2020-03-25 | — | — | EP | claimed |
| US-20190093236-A1 | COMPOSITIONS OF VAPOR PHASE CORROSION INHIBITORS AND THEIR USE AS WELL AS METHODS FOR THEIR MANUFACTURE | EXCOR KORROSIONSFORSCHUNG GMBH (DE) | 2019-03-28 | — | — | US | claimed |
| JP-2138146-A | — | — | None | — | — | JP | disclosed |
| EP-4153555-B1 | PHOTOOXIDATION OF PHENOLIC COMPOUNDS | DSM IP ASSETS BV (NL) | 2024-01-31 | — | — | EP | disclosed |
| US-11831017-B2 | Redox flow battery electrolytes | CMBLU ENERGY AG (DE) | 2023-11-28 | — | — | US | disclosed |
| US-11788228-B2 | Methods for processing lignocellulosic material | CMBLU ENERGY AG (DE) | 2023-10-17 | — | — | US | disclosed |
| US-11773537-B2 | Sulfonated lignin-derived compounds and uses thereof | CMBLU ENERGY AG (DE) | 2023-10-03 | — | — | US | disclosed |
| US-20230304221-A1 | Sulfonated Lignin-Derived Compounds And Uses Thereof | CMBLU ENERGY AG (DE) | 2023-09-28 | — | — | US | disclosed |
| US-11731945-B2 | Redox-active compounds and uses thereof | CMBLU ENERGY AG (DE) | 2023-08-22 | — | — | US | disclosed |
| EP-2500336-A1 | PHARMACEUTICAL SUBSTANCES ON THE BASIS OF MITOCHONDRIALLY ADDRESSED ANTIOXIDANTS | Obschestvo S Ogranichennoi Otvetstvennostyu "Mitotekh" (RU) | 2012-09-19 | — | — | EP | disclosed |
| CN-101627983-B | Pharmaceutical composition for inhibiting angiogenesis and application thereof | GRAPE KING INC | 2012-03-14 | — | — | CN | disclosed |
| US-20110287106-A1 | COGNITIVE IMPAIRMENT AMELIORANT | JAPAN ROYAL JELLEY CO., LTD. (JP) | 2011-11-24 | — | — | US | disclosed |
| CN-101627983-A | Pharmaceutical composition for inhibiting angiogenesis and application thereof | GRAPE KING INC | 2010-01-20 | — | — | CN | disclosed |
| US-5032506-A | Color control system | ENZYMATICS, INC. (US) | 1991-07-16 | — | — | US | disclosed |
| EP-0279988-B1 | DIGITAL THRESHOLD COLOUR CONTROL SYSTEM | ENZYMATICS, INC. (US) | 1991-04-24 | — | — | EP | disclosed |
| JP-H02138146-A | PRODUCTION OF METHOXY-SUBSTITUTED P-BENZOQUINONES | AGENCY OF IND SCIENCE & TECHNOL | 1990-05-28 | — | — | JP | disclosed |
| EP-0279988-A1 | Digital threshold colour control system | ENZYMATICS, INC. (US) | 1988-08-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11788228-B2 | Methods for processing lignocellulosic material | DCXR, LCT, AGL | MAPT 1450/4885MEN1 3558/4885KMT2A 2116/4885 |
| US-11773537-B2 | Sulfonated lignin-derived compounds and uses thereof | SQOR, NQO1, NOX4 | MAPT 1074/4885MEN1 4773/4885KMT2A 2318/4885 |
| US-11731945-B2 | Redox-active compounds and uses thereof | NOX4, NQO1, GPX1 | MAPT 1567/4885MEN1 4552/4885KMT2A 1859/4885 |
| US-11831017-B2 | Redox flow battery electrolytes | GPX1, GPX4, NOX4 | MAPT 3707/4885MEN1 3578/4885KMT2A 3564/4885 |
| US-20230304221-A1 | Sulfonated Lignin-Derived Compounds And Uses Thereof | SQOR, NQO1, NOX4 | MAPT 1074/4885MEN1 4773/4885KMT2A 2318/4885 |
| US-20110287106-A1 | COGNITIVE IMPAIRMENT AMELIORANT | CHAT, ACHE, PSEN1 | MAPT 7/4885MEN1 3488/4885KMT2A 768/4885 |
| US-20220409554-A1 | ASCORBIC ACID AND QUINONE COMPOUND FOR CANCER TREATMENT | NQO1, SDHB, SDHA | MAPT 3180/4885MEN1 845/4885KMT2A 2530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.